Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 Biomarker disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL) is a childhood neurodegenerative disease caused by the selective death of cortical neurons and retinal degeneration, as the result of a palmitoyl protein thioesterase 1 (PPT1) deficiency. 11020216 2000
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 GeneticVariation disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL) is a severe neurodegenerative storage disorder in children caused by mutations in the palmitoyl protein thioesterase gene (PPT1). 11520175 2001
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 Biomarker disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL) is a childhood neurodegenerative disease caused by the selective death of cortical and retinal neurons as the result of an inherited palmitoyl-protein thioesterase 1 (PPT1) deficiency. 11589008 2001
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 Biomarker disease MGD Infantile Neuronal Ceroid Lipofuscinosis (INCL) results from mutations in the palmitoyl protein thioesterase (PPT1, CLN1) gene and is characterized by dramatic death of cortical neurons. 15649713 2005
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 Biomarker disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL) has the earliest onset ( approximately 1.5 years of age) and is caused by a deficiency in the lysosomal enzyme palmitoyl protein thioesterase-1 (PPT1). 16364693 2006
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 GeneticVariation disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL) is a severe neurodegenerative disorder of the childhood caused by mutations in the gene encoding palmitoyl protein thioesterase 1 (PPT1). 16542649 2006
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 GeneticVariation disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL), a neurodegenerative storage disorder of childhood, is caused by mutations in the palmitoyl-protein thioesterase-1 (PPT1) gene. 16644870 2006
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 Biomarker disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL) is a severe neurodegenerative disease caused by deficiency of palmitoyl protein thioesterase 1 (PPT1). 18245779 2008
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 Biomarker disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL) is caused by palmitoyl protein thioesterase-1 (PPT1) deficiency. 18704195 2008
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 Biomarker disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL) is a fatal neurodegenerative disease caused by a deficiency in the lysosomal enzyme palmitoyl protein thioesterase-1 (PPT1). 19733542 2009
Entrez Id: 825
Gene Symbol: CAPN3
CAPN3
0.010 AlteredExpression disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL; NCL1, Haltia-Santavuori disease) is caused by mutations in the CLN1/PPT gene which are associated with an early onset INCL phenotype. 22387303 2012
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 GeneticVariation disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL; NCL1, Haltia-Santavuori disease) is caused by mutations in the CLN1/PPT gene which are associated with an early onset INCL phenotype. 22387303 2012
Entrez Id: 6863
Gene Symbol: TAC1
TAC1
0.030 GeneticVariation disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL; NCL1, Haltia-Santavuori disease) is caused by mutations in the CLN1/PPT gene which are associated with an early onset INCL phenotype. 22387303 2012
Entrez Id: 5536
Gene Symbol: PPP5C
PPP5C
0.030 GeneticVariation disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL; NCL1, Haltia-Santavuori disease) is caused by mutations in the CLN1/PPT gene which are associated with an early onset INCL phenotype. 22387303 2012
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 GeneticVariation disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL) is an autosomal recessive disorder starting in infancy as early as 12-month-old, caused by PPT1 (palmitoyl-protein thioesterase 1) mutations, and characterized by progressive psychomotor deterioration, brain atrophy, myoclonic jerk and visual impairment. 26846731 2016
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 GeneticVariation disease BEFREE Infantile neuronal ceroid lipofuscinosis (INCL, CLN1) is a neurodegenerative disorder in which the biochemical defect is unknown. 7789974 1995
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 Biomarker disease BEFREE Palmitoyl-protein thioesterase-1 (PPT1) deficiency causes infantile neuronal ceroid lipofuscinosis (INCL), a devastating childhood neurodegenerative storage disorder. 18948101 2008
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 Biomarker disease CTD_human Decreased sensitivity of palmitoyl protein thioesterase 1-deficient neurons to chemical anoxia. 27722792 2017
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 GeneticVariation disease BEFREE Deficiency in this enzyme leads to infantile neuronal ceroid lipofuscinosis (INCL, Infantile Batten disease, CLN1). 30204428 2018
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 GeneticVariation disease BEFREE Detection of eight novel palmitoyl protein thioesterase (PPT) mutations underlying infantile neuronal ceroid lipofuscinosis (INCL;CLN1). 10679943 2000
Entrez Id: 5538
Gene Symbol: PPT1
PPT1
0.600 Biomarker disease CTD_human Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol. 21224254 2011
Entrez Id: 10891
Gene Symbol: PPARGC1A
PPARGC1A
0.300 Biomarker disease CTD_human Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol. 21224254 2011
Entrez Id: 6855
Gene Symbol: SYP
SYP
0.300 Biomarker disease CTD_human Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol. 21224254 2011
Entrez Id: 51024
Gene Symbol: FIS1
FIS1
0.300 Biomarker disease CTD_human Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol. 21224254 2011
Entrez Id: 2670
Gene Symbol: GFAP
GFAP
0.300 Biomarker disease CTD_human Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol. 21224254 2011